Eupraxia Pharmaceuticals Statistics

Total Valuation

TSX:EPRX has a market cap or net worth of CAD 668.95 million. The enterprise value is 517.18 million.

Market Cap	668.95M
Enterprise Value	517.18M

Important Dates

The next estimated earnings date is Monday, August 10, 2026.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:EPRX has 65.33 million shares outstanding. The number of shares has increased by 26.83% in one year.

Current Share Class	65.33M
Shares Outstanding	65.33M
Shares Change (YoY)	+26.83%
Shares Change (QoQ)	+10.56%
Owned by Insiders (%)	17.11%
Owned by Institutions (%)	35.46%
Float	50.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.52
P/TBV Ratio	4.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.89
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.08

Financial Position

The company has a current ratio of 19.30, with a Debt / Equity ratio of 0.01.

Current Ratio	19.30
Quick Ratio	18.95
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.06
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.52% and return on invested capital (ROIC) is -35.75%.

Return on Equity (ROE)	-54.52%
Return on Assets (ROA)	-33.84%
Return on Invested Capital (ROIC)	-35.75%
Return on Capital Employed (ROCE)	-34.25%
Weighted Average Cost of Capital (WACC)	12.01%
Revenue Per Employee	n/a
Profits Per Employee	-1.34M
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:EPRX has paid 42,158 in taxes.

Income Tax	42,158
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +94.68% in the last 52 weeks. The beta is 1.42, so TSX:EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	+94.68%
50-Day Moving Average	9.91
200-Day Moving Average	9.41
Relative Strength Index (RSI)	53.90
Average Volume (20 Days)	50,671

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-65.98M
Pretax Income	-62.06M
Net Income	-65.58M
EBITDA	-65.70M
EBIT	-65.98M
Earnings Per Share (EPS)	-1.45

Full Income Statement

Balance Sheet

The company has 193.86 million in cash and 2.80 million in debt, with a net cash position of 191.05 million or 2.92 per share.

Cash & Cash Equivalents	193.86M
Total Debt	2.80M
Net Cash	191.05M
Net Cash Per Share	2.92
Equity (Book Value)	190.10M
Book Value Per Share	2.44
Working Capital	188.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -45.64 million and capital expenditures -1.04 million, giving a free cash flow of -46.68 million.

Operating Cash Flow	-45.64M
Capital Expenditures	-1.04M
Depreciation & Amortization	287,720
Net Borrowing	n/a
Free Cash Flow	-46.68M
FCF Per Share	-0.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.83%
Shareholder Yield	-26.83%
Earnings Yield	-9.80%
FCF Yield	-6.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2